Study of Single And Double Bundle Anterior Cruciate Ligament (ACL) Graft Cross-sectional Dimensions

NCT ID: NCT02834962

Last Updated: 2016-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To study the difference between single and double bundle ACL graft cross-sectional dimensions compared with native ACL using postoperative 3-D MRI.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators divide 100 patients with ACL rupture into 2 groups. Group A undergo single bundle anterior cruciate ligament reconstruction (ACLR). Group B undergo double bundle ACL reconstruction. At 3-6 weeks post operation, all the patients undergo 3-D MRI examination of both knees. The investigators reconstruct 3-D models of reconstructed ACL and native ACL, and compare the difference between single and double bundle graft.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rupture of Anterior Cruciate Ligament

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

single bundle ACLR

patients undergo single bundle ACL reconstruction

Group Type EXPERIMENTAL

single bundle ACL reconstruction

Intervention Type PROCEDURE

anterior cruciate ligament reconstruction using single bundle technique

double bundle ACLR

patients undergo double bundle ACL reconstruction

Group Type ACTIVE_COMPARATOR

double bundle ACL reconstruction

Intervention Type PROCEDURE

anterior cruciate ligament reconstruction using double bundle technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

single bundle ACL reconstruction

anterior cruciate ligament reconstruction using single bundle technique

Intervention Type PROCEDURE

double bundle ACL reconstruction

anterior cruciate ligament reconstruction using double bundle technique

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ACL rupture patients aged between 10 to 50 years

Exclusion Criteria

* combined severe injuries to the operated knee (additional ligament rupture, major meniscus loss, patella instability, cartilage damage \>2°, pathologic leg axis deviation)
* any injury or surgery to the contralateral knee
* any inflammatory or systemic disease, neuromuscular disease in the lower limbs,any recent knee infection
Minimum Eligible Age

10 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University Third Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jia-kuo yu

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jia-Kuo Yu

Role: STUDY_CHAIR

Peking University Third Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yu Jia-Kuo, MD

Role: CONTACT

86-10-82267392

Liu Yang, MD

Role: CONTACT

86-10-82267019

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ACLMRI-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.